National Institute of Allergy and Infectious Diseases | |
The National Institute of Allergy and Infectious Diseases (NIAID, pronounced "NYE-ad") traces its origins to 1887 when Dr. Joseph Kinyoun set up a bacteriologic laboratory at the Marine Hospital on Staten Island. He was the first to identify the bacteria that causes cholera. By 1891, Congress was funding Kinyoun's Hygienic Laboratory to investigate contagious diseases and promote public health. In 1930, it became the first National Institute of Health. Its next big success was finding the cause of Rocky Mountain spotted fever. In 1948, more NIH institutes were created, and the NIAID became one part of the National Institutes of Health. In 1955, its work on allergies and immunology was formally recognized with a change to its current name. Today, its research leads to new vaccines, therapies, and diagnostic tests. The 2021 budget was $6.1 billion, spent mostly on research, with a small fraction for about 2,000 full-time employees. Divisions within NIAID are focused on
The NIAID is always on the front line in responding to emerging diseases. Their goal is to be flexible and absorb every scrap of newly available knowledge about disease threats, including COVID-19, tuberculosis, influenza, HIV/AIDS, asthma, and allergies. News from NIAID-Funded Research includes
The NIAID has been led by an immunologist, Dr. Anthony Fauci, since 1984. Fauci was born and raised in New York City and received his medical degree from Cornell University. He is also the Chief Medical Advisor to the President. He has turned down the opportunity to lead the National Institutes of Health more than once. The Web of Science finds him ranked 9th out of 2.5 million authors in the field of immunology based on his total research citations from 1980 to 2021. | |
|
No comments:
Post a Comment
Let us know what you think about today's commentary!